Peng Q, Moan J
Department of Pathology, Norwegian Radium Hospital, Montebello, Oslo.
Br J Cancer. 1995 Sep;72(3):565-74. doi: 10.1038/bjc.1995.375.
A chemical extraction assay and fluorescence microscopy incorporating a light-sensitive thermoelectrically cooled charge-coupled device (CCD) camera was used to study the kinetics of uptake, retention and localisation of disulphonated aluminium phthalocyanine (A1PcS2) and tetrasulphonated aluminium phthalocyanine (A1PcS4) at different time intervals after an i.p. injection at a dose of 10 mg kg-1 body weight (b.w.) in tumour and surrounding normal skin and muscle of female C3D2/F1 mice bearing CaD2 mammary carcinoma. Moreover, the photodynamic effect on the tumour and normal skin using sulphonated aluminium phthalocyanines (A1PcS1, A1PcS2, A1pcS4) and Photofrin was compared with respect to dye, dye dose and time interval between dye administration and light exposure. The maximal concentrations of A1PcS2 in the tumour tissue were reached 2-24 h after injection of the dye, while the amounts of A1PcS4 peaked 1-2 h after the dye administration. A1PcS2 was simultaneously localised in the interstitium and in the neoplastic cells of the tumour, whereas A1PcS4 appeared to localise only in the stroma of the tumour. The photodynamic efficiency (light was applied 24 h after dye injection at a dose of 10 mg kg-1 b.w.) of the tumours was found to decrease in the following order: A1PcS2 > A1PcS4 > Photofrin > A1PcS1. Furthermore, photodynamic efficacy was strongly dependent upon dye doses and time intervals between dye administration and light exposure: the higher the dose, the higher the photodynamic efficiency. The most efficient photodynamic therapy (PDT) of the tumour was reached (day 20 tumour-free) when light exposure took place 2 h after injection of A1PcS2 (10 mg kg-1). A dual intratumoral localisation pattern of the dye, as found for A1PcS2, seems desirable to obtain a high photodynamic efficiency. The kinetic patterns of uptake, retention and localisation of A1PcS2 and A1PcS4 are roughly correlated with their photodynamic effect on the tumour and normal skin.
采用化学提取分析和荧光显微镜技术,并结合光敏感热电冷却电荷耦合器件(CCD)相机,研究了腹腔注射剂量为10mg/kg体重(b.w.)的二磺化铝酞菁(A1PcS2)和四磺化铝酞菁(A1PcS4)后,在不同时间间隔内,荷CaD2乳腺癌的雌性C3D2/F1小鼠肿瘤及周围正常皮肤和肌肉中药物的摄取、保留和定位动力学。此外,比较了磺化铝酞菁(A1PcS1、A1PcS2、A1PcS4)和光敏剂对肿瘤和正常皮肤的光动力效应,涉及染料、染料剂量以及染料给药与光照之间的时间间隔。注射染料后2-24小时,肿瘤组织中A1PcS2的浓度达到最大值,而A1PcS4的量在给药后1-2小时达到峰值。A1PcS2同时定位于肿瘤的间质和肿瘤细胞中,而A1PcS4似乎仅定位于肿瘤的基质中。发现肿瘤的光动力效率(染料注射后24小时以10mg/kg体重的剂量照射光)按以下顺序降低:A1PcS2>A1PcS4>光敏剂>A1PcS1。此外,光动力疗效强烈依赖于染料剂量以及染料给药与光照之间的时间间隔:剂量越高,光动力效率越高。当在注射A1PcS2(10mg/kg)后2小时进行光照时,达到了最有效的肿瘤光动力治疗(第20天无肿瘤)。如A1PcS2所示的染料双肿瘤内定位模式似乎有利于获得高光动力效率。A1PcS2和A1PcS4的摄取、保留和定位动力学模式与其对肿瘤和正常皮肤的光动力效应大致相关。